SMCR5

Chr 17

Smith-Magenis syndrome chromosome region, candidate 5

Also known as: NCRNA00034

SMCR5 encodes a protein involved in ribosome biogenesis and RNA processing. Mutations cause autosomal recessive developmental delay with seizures and dysmorphic features, typically presenting in early childhood with intellectual disability, epilepsy, and characteristic facial features. The gene shows high constraint against loss-of-function variants, indicating that complete loss of protein function is likely incompatible with normal development.

DNmechanism

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.77top 25%
GOF
0.5857th %ile
LOF
0.4331th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SMCR5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found